PHGE — Biomx Income Statement
0.000.00%
HealthcareSpeculativeMicro CapNeutral
- $11.71m
- -$14.07m
- 29
- 52
- 20
- 24
Annual income statement for Biomx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 0.001 | 0.405 | 30.3 | 35.5 |
Operating Profit | -0.001 | -0.405 | -30.3 | -35.5 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -0.001 | 0.483 | -30.1 | -36.2 |
Provision for Income Taxes | ||||
Net Income After Taxes | -0.001 | 0.347 | -30.1 | -36.2 |
Net Income Before Extraordinary Items | ||||
Net Income | -0.001 | 0.347 | -30.1 | -36.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -0.001 | 0.347 | -30.1 | -36.2 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.001 | 0.174 | -1.3 | -1.39 |
Dividends per Share |